Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)의 가격은 얼마입니까?

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)의 가격은 $1.15입니다.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)의 시가 총액은 무엇입니까?

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)의 시가 총액은 $88.79M입니다.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) 수익

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

연도	매출	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

매출

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	매출	매출 차이	국가
Royalty Pharma plc RPRX.US	$2.54B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$830.81M	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

회사

매출

매출 차이

국가